Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy

This retrospective pooled analysis aims to identify factors predicting relapse despite a pathologic complete response (pCR) in patients with breast cancer (BC). 2066 patients with a pCR from five neoadjuvant GBG/AGO-B trials fulfill the inclusion criteria of this analysis. Primary endpoint is diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Huober, Jens, van Mackelenbergh, Marion, Schneeweiss, Andreas, Seither, Fenja, Blohmer, Jens-Uwe, Denkert, Carsten, Tesch, Hans, Hanusch, Claus, Salat, Christoph, Rhiem, Kerstin, Solbach, Christine, Fasching, Peter A., Jackisch, Christian, Reinisch, Mattea, Lederer, Bianca, Mehta, Keyur, Link, Theresa, Nekljudova, Valentina, Loibl, Sibylle, Untch, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082019/
https://www.ncbi.nlm.nih.gov/pubmed/37029138
http://dx.doi.org/10.1038/s41523-023-00525-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082019/
https://www.ncbi.nlm.nih.gov/pubmed/37029138
http://dx.doi.org/10.1038/s41523-023-00525-2

Ejemplares similares